Tolka AI Therapeutics
PrivateLast Round
Seed
Jun 13, 2024
Company Overview
Tolka AI Therapeutics is a biotechnology company that has developed an AI-based platform for drug discovery for complex inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery, Medical AI, Clinical Trials
Business Model
B2B2C
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tolka AI Therapeutics Comparables
Compare Tolka AI Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Medea Biopharma | 73% | |
| Locus Biosciences | 73% | |
| BioNTech | 69% | |
Tolka AI Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jun 13, 2024 |
Tolka AI Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Khosla Ventures | Angel |
| NIH RADx | Angel |
| Draper Associates | Angel |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 3, 2026
Monthly visitors increased 269% MoM.
- Dec 4, 2025
Monthly visitors increased 53% MoM.
Tolka AI Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Tolka AI Therapeutics's valuation, stock price, and market status.